Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants

Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants

Background/Aim. Autologous stem cell transplants (ASCTs) improve the rate of overall survival (OS) in patients with hematological malignancies such as multiple myeloma (MM) after induction chemotherapy, aggressive non-Hodgkin's lymphomas (NHL), and relapsed, chemotherapy- sensitive Hodgkin'...

Full description

Bibliographic Details
Main Authors: Todorović-Balint Milena, Bila Jelena, Balint Bela, Jeličić Jelena, Đunić Irena, Antić Darko, Kraguljac-Kurtović Nada, Vujić Dragana, Mihaljević Biljana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2020-01-01
Series:Vojnosanitetski Pregled
Subjects:
hematologic neoplasms
stem cells
transplantation, autologous
survival
flow cytometry
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800160T.pdf

Similar Items

Similar Items